Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 10.

Schwartz, Gregory G; Steg, P Gabriel; Szarek, Michael; Bhatt, Deepak L; Bittner, Vera A; Diaz, Rafael; Edelberg, Jay M; Goodman, Shaun G; Hanotin, Corinne; Harrington, Robert A; Jukema, J Wouter; Lecorps, Guillaume; Mahaffey, Kenneth W; Moryusef, Angèle; Pordy, Robert; Quintero, Kirby; Roe, Matthew T; Sasiela, William J; Tamby, Jean-François; Tricoci, Pierluigi; White, Harvey D; Zeiher, Andreas M (2018). Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome. New England Journal of Medicine, 379(22):2097-2107.

Simic, Branko; Mocharla, Pavani; Crucet, Margot; Osto, Elena; Kratzer, Adelheid; Stivala, Simona; Kühnast, Susan; Speer, Thimoteus; Doycheva, Petia; Princen, Hans M; van der Hoorn, Jose W; Jukema, J Wouter; Giral, Hector; Tailleux, Anne; Landmesser, Ulf; Staels, Bart; Lüscher, Thomas F (2017). Anacetrapib, but not evacetrapib, impairs endothelial function in CETP-transgenic mice in spite of marked HDL-C increase. Atherosclerosis, 257:186-194.

Zeymer, Uwe; Widimsky, Petr; Danchin, Nicolas; Lettino, Maddalena; Bardaji, Alfredo; Barrabes, Jose A; Cequier, Angel; Claeys, Marc J; De Luca, Leonardo; Dörler, Jakob; Erlinge, David; Erne, Paul; Goldstein, Patrick; Koul, Sasha M; Lemesle, Gilles; Lüscher, Thomas F; Matter, Christian M; Montalescot, Gilles; Radovanovic, Dragana; Sendón, Jose Lopez; Tousek, Petr; Weidinger, Franz; Weston, Clive F M; Zaman, Azfar; Andell, Pontus; Li, Jin; Jukema, J Wouter (2016). P2Y12 receptor inhibitors in patients with non-ST-elevation acute coronary syndrome in the real world: use, patient selection, and outcomes from contemporary European registries. European Heart Journal - Cardiovascular Pharmacotherapy, 2(4):229-243.

Danchin, Nicolas; Lettino, Maddalena; Zeymer, Uwe; Widimsky, Petr; Bardaji, Alfredo; Barrabes, Jose A; Cequier, Angel; Claeys, Marc J; De Luca, Leonardo; Dörler, Jakob; Erlinge, David; Erne, Paul; Goldstein, Patrick; Koul, Sasha M; Lemesle, Gilles; Lüscher, Thomas F; Matter, Christian M; Montalescot, Gilles; Radovanovic, Dragana; Lopez Sendón, Jose; Tousek, Petr; Weidinger, Franz; Weston, Clive F M; Zaman, Azfar; Andell, Pontus; Li, Jin; Jukema, J Wouter (2016). Use, patient selection and outcomes of P2Y12 receptor inhibitor treatment in patients with STEMI based on contemporary European registries. European Heart Journal - Cardiovascular Pharmacotherapy, 2(3):152-167.

Anker, Stefan D; Schroeder, Stefan; Atar, Dan; Bax, Jeroen J; Ceconi, Claudio; Cowie, Martin R; Crisp, Adam; Dominjon, Fabienne; Ford, Ian; Ghofrani, Hossein-Ardeschir; Gropper, Savion; Hindricks, Gerhard; Hlatky, Mark A; Holcomb, Richard; Honarpour, Narimon; Jukema, J Wouter; Kim, Albert M; Kunz, Michael; Lefkowitz, Martin; Floch, Chantal Le; Landmesser, Ulf; McDonagh, Theresa A; McMurray, John J; Merkely, Bela; Packer, Milton; Prasad, Krishna; Revkin, James; Rosano, Giuseppe M C; Somaratne, Ransi; Stough, Wendy Gattis; et al (2016). Erratum to "Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency" [Eur J Heart Fail 2016;18:482-489]. European Journal of Heart Failure, 18(6):727.

Anker, Stefan D; Schroeder, Stefan; Atar, Dan; Bax, Jeroen J; Ceconi, Claudio; Cowie, Martin R; Crisp, Adam; Dominjon, Fabienne; Ford, Ian; Ghofrani, Hossein-Ardeschir; Gropper, Savion; Hindricks, Gerhard; Hlatky, Mark A; Holcomb, Richard; Honarpour, Narimon; Jukema, J Wouter; Kim, Albert M; Kunz, Michael; Lefkowitz, Martin; Le Floch, Chantal; Landmesser, Ulf; McDonagh, Theresa A; McMurray, John J; Merkely, Bela; Packer, Milton; Prasad, Krishna; Revkin, James; Rosano, Giuseppe M C; Somaratne, Ransi; Stough, Wendy Gattis; et al (2016). Traditional and new composite endpoints in heart failure clinical trials: facilitating comprehensive efficacy assessments and improving trial efficiency. European Journal of Heart Failure, 18(5):482-489.

Jukema, J Wouter; Brouwer, Judith R; Lüscher, Thomas F; Engberts, Dick P; Quax, Paul H A (2015). Research ethics needs fine tuning, not rigidity: how to promote evidence in neglected patient populations by rethinking informed consent. European Heart Journal, 36(40):2681-2685.

Kühnast, Susan; van der Tuin, Sam J L; van der Hoorn, José W A; van Klinken, Jan B; Simic, Branko; Pieterman, Elsbet; Havekes, Louis M; Landmesser, Ulf; Lüscher, Thomas F; Willems van Dijk, Ko; Rensen, Patrick C N; Jukema, J Wouter; Princen, Hans M G (2015). Anacetrapib reduces progression of atherosclerosis, mainly by reducing non-HDL-cholesterol, improves lesion stability and adds to the beneficial effects of atorvastatin. European Heart Journal, 36(1):39-50.

Lüscher, Thomas F; Taddei, Stefano; Kaski, Juan-Carlos; Jukema, J Wouter; Kallend, David; Münzel, Thomas; Kastelein, John JP; Deanfield, John E (2012). Vascular effects and safety of dalcetrapib in patients with or at risk of coronary heart disease: the dal-VESSEL randomized clinical trial. European Heart Journal, 33(7):857-865.

Veltman, Caroline E; de Graaf, Fleur R; Schuijf, Joanne D; van Werkhoven, Jacob M; Jukema, J Wouter; Kaufmann, Philipp A; Pazhenkottil, Aju P; Kroft, Lucia J; Boersma, Eric; Bax, Jeroen J; Schalij, Martin J; van der Wall, Ernst E (2012). Prognostic value of coronary vessel dominance in relation to significant coronary artery disease determined with non-invasive computed tomography coronary angiography. European Heart Journal, 33(11):1367-1377.

This list was generated on Mon Jun 17 16:53:50 2019 CEST.